Mark Goodman

1.4k total citations
52 papers, 903 citations indexed

About

Mark Goodman is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Mark Goodman has authored 52 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 16 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Mark Goodman's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Mark Goodman is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Mark Goodman collaborates with scholars based in United States, Norway and Italy. Mark Goodman's co-authors include Hugo F. Fernández, Denise Pereira, Krishna V. Komanduri, Lazaros J. Lekakis, Amer Beitinjaneh, Kelvin P. Lee, Lawrence Boise, Mohamed A. Kharfan‐Dabaja, James R. Eckman and Antonio Jiménez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mark Goodman

47 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Goodman United States 16 287 261 260 137 114 52 903
Jiří Vorlíček Czechia 17 492 1.7× 268 1.0× 227 0.9× 147 1.1× 56 0.5× 98 969
Masaru Ido Japan 18 273 1.0× 200 0.8× 277 1.1× 245 1.8× 65 0.6× 80 1.1k
Fotini Tzortzatou‐Stathopoulou Greece 20 328 1.1× 213 0.8× 565 2.2× 83 0.6× 72 0.6× 67 1.3k
Claire Oudin France 21 550 1.9× 193 0.7× 277 1.1× 130 0.9× 73 0.6× 39 1.1k
Karon Abe United States 18 144 0.5× 119 0.5× 475 1.8× 97 0.7× 72 0.6× 46 1.2k
Renée M. Ned United States 18 297 1.0× 112 0.4× 296 1.1× 184 1.3× 91 0.8× 31 1.3k
Bernhard Fischer Austria 20 220 0.8× 179 0.7× 419 1.6× 158 1.2× 44 0.4× 85 1.4k
Katrin Roth Germany 16 149 0.5× 131 0.5× 237 0.9× 319 2.3× 32 0.3× 49 1.2k
Lilia Goudeva Germany 21 141 0.5× 366 1.4× 196 0.8× 266 1.9× 122 1.1× 35 1.1k

Countries citing papers authored by Mark Goodman

Since Specialization
Citations

This map shows the geographic impact of Mark Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Goodman more than expected).

Fields of papers citing papers by Mark Goodman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Goodman. The network helps show where Mark Goodman may publish in the future.

Co-authorship network of co-authors of Mark Goodman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Goodman. A scholar is included among the top collaborators of Mark Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Goodman. Mark Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiménez, Adriana, Mark Goodman, Lazaros J. Lekakis, et al.. (2026). Cytomegalovirus Lymphadenitis Mimicking Relapsed Lymphoma After CD19 Chimeric Antigen Receptor ( CAR ) T Cell Therapy. Apmis. 134(2). e70172–e70172.
2.
Anderson, Anthony D., Yoichiro Natori, Mohammed Raja, et al.. (2024). Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy. Blood Advances. 8(14). 3813–3822. 12 indexed citations
3.
Anderson, Anthony D., Mohammed Raja, Michele I. Morris, et al.. (2023). Incidence and Outcomes of Cytomegalovirus Reactivation after Chimeric Antigen Receptor T Cell Therapy. Blood. 142(Supplement 1). 3516–3516. 3 indexed citations
4.
Jiménez, Antonio, Krishna V. Komanduri, Samantha Brown, et al.. (2022). Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant. Blood Advances. 6(15). 4491–4500. 10 indexed citations
5.
Husnain, Muhammad, Deukwoo Kwon, Michelle Saul, et al.. (2021). Clinical Outcomes in Acute Myeloid Leukemia (AML) Patients (Pts) Carrying Isocitrate Dehydrogenase (IDH1-2) Mutations Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT). Transplantation and Cellular Therapy. 27(3). S147–S148. 1 indexed citations
6.
Camargo, José F., Maria A. Mendoza, Anthony D. Anderson, et al.. (2021). Clinical presentation and outcomes of COVID‐19 following hematopoietic cell transplantation and cellular therapy. Transplant Infectious Disease. 23(4). e13625–e13625. 19 indexed citations
7.
Camargo, José F., Yoichiro Natori, Michele I. Morris, et al.. (2021). Lower Incidence of Cytomegalovirus Reactivation Following Post-Transplantation Cyclophosphamide HLA-Mismatched Unrelated Donor Transplantation. Transplantation and Cellular Therapy. 27(12). 1017.e1–1017.e7. 5 indexed citations
8.
Morris, Michele I., Mark Goodman, Denise Pereira, et al.. (2017). Syndrome of Inappropriate Anti-Diuretic Hormone Secretion Secondary to Strongyloides stercoralis Infection in an Allogeneic Stem Cell Transplant Patient: A Case Report and Literature Review. Transplantation Proceedings. 49(2). 373–377. 9 indexed citations
9.
Desai, Amrita, Amer Beitinjaneh, Jeremy Ramdial, et al.. (2017). Safety of High-Dose Melphalan (200 Mg/M2) as Conditioning for Autologous Stem Cell Transplantation for Myeloma in Elderly Patients. Biology of Blood and Marrow Transplantation. 23(3). S133–S134. 2 indexed citations
10.
Schuster, David M., Cristina Nanni, Stefano Fanti, et al.. (2014). Anti-1-Amino-3-F-18-Fluorocyclobutane-1-Carboxylic Acid: Physiologic Uptake Patterns, Incidental Findings, and Variants That May Simulate Disease. Journal of Nuclear Medicine & Radiation Therapy. 55(12). 1986–1992. 20 indexed citations
11.
Bayraktar, Soley, et al.. (2010). Primary Pituitary Lymphoma: Idiopathic Anasarca with Relapse in Bone Marrow Only. Acta Haematologica. 123(2). 121–125. 5 indexed citations
12.
Escalón, Maricer P., Alexandra Stefanovic, Denise Pereira, et al.. (2009). Autologous transplantation for relapsed non-Hodgkin's lymphoma using intravenous busulfan and cyclophosphamide as conditioning regimen: a single center experience. Bone Marrow Transplantation. 44(2). 89–96. 11 indexed citations
13.
Morgensztern, Daniel, Manuel F. Rosado, Orlando Silva, et al.. (2004). Prevalence of Hepatitis C Infection in Patients with Non-Hodgkin's Lymphoma in South Florida and Review of the Literature. Leukemia & lymphoma. 45(12). 2459–2464. 14 indexed citations
14.
Santos, Edgardo S., Joseph D. Rosenblatt, & Mark Goodman. (2004). Role of farnesyltransferase inhibitors in hematologic malignancies. Expert Review of Anticancer Therapy. 4(5). 843–856. 3 indexed citations
15.
Kharfan-Dabaja, M A, et al.. (2003). Acute graft-versus-host disease (aGVHD) presenting with an acquired lupus anticoagulant. Bone Marrow Transplantation. 31(2). 129–131. 1 indexed citations
16.
17.
Koya, Richard C., Janet Andersen, Hugo F. Fernández, et al.. (1998). Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants. Bone Marrow Transplantation. 21(9). 923–926. 13 indexed citations
18.
Goodman, Mark, et al.. (1998). Interleukin-2 and leukemia. Leukemia. 12(11). 1671–1675. 24 indexed citations
19.
Goodman, Mark, et al.. (1998). Interleukin-2 therapy for advanced chronic myeloid leukemia. Leukemia. 12(11). 1682–1684. 3 indexed citations
20.
Burgess, Ellen S., et al.. (1997). Predictors of Psychosocial Adjustment in Patients with Implantable Cardioverter Defibrillators. Pacing and Clinical Electrophysiology. 20(7). 1790–1795. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiří Vorlíček Breakdown of academic impact, for papers by Masaru Ido Breakdown of academic impact, for papers by Fotini Tzortzatou‐Stathopoulou Breakdown of academic impact, for papers by Claire Oudin Breakdown of academic impact, for papers by Karon Abe Breakdown of academic impact, for papers by Renée M. Ned Breakdown of academic impact, for papers by Bernhard Fischer Breakdown of academic impact, for papers by Katrin Roth Breakdown of academic impact, for papers by Lilia Goudeva
Rankless by CCL
2026